We are live on ! Find out more
TECH icon

Bio-Techne

355 hedge funds and large institutions have $7.06B invested in Bio-Techne in 2019 Q1 according to their latest regulatory filings, with 56 funds opening new positions, 127 increasing their positions, 110 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more funds holding in top 10

Funds holding in top 10: 25 (+3)

133% more first-time investments, than exits

New positions opened: 56 | Existing positions closed: 24

38% more capital invested

Capital invested by funds: $5.12B → $7.06B (+$1.94B)

15% more repeat investments, than reductions

Existing positions increased: 127 | Existing positions reduced: 110

9% more funds holding

Funds holding: 327355 (+28)

0.05% less ownership

Funds ownership: 376.56%376.51% (-0.05%)

34% less call options, than puts

Call options by funds: $2.94M | Put options by funds: $4.47M

Holders
355
Holders Change
+28
Holders Change %
+8.56%
% of All Funds
7.68%
Holding in Top 10
5
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+150%
% of All Funds
0.11%
New
56
Increased
127
Reduced
110
Closed
24
Calls
$2.94M
Puts
$4.47M
Net Calls
-$1.53M
Net Calls Change
-$2.27M
Name Holding Trade Value Shares
Change
Change in
Stake
Northern Trust
26
Northern Trust
Illinois
$66.8M +$1.44M +31,944 +2%
CCA
27
Conestoga Capital Advisors
Pennsylvania
$63.8M +$369K +8,204 +0.6%
O
28
OppenheimerFunds
New York
$60.3M +$5.72M +127,052 +12%
SBH
29
Segall Bryant & Hamill
Illinois
$54.5M +$1.6M +35,576 +3%
RA
30
Royce & Associates
New York
$52.7M -$6.01M -133,600 -11%
KCM
31
Kornitzer Capital Management
Kansas
$50.4M -$523K -11,632 -1%
SEI Investments
32
SEI Investments
Pennsylvania
$49.5M +$12.6M +280,288 +39%
Millennium Management
33
Millennium Management
New York
$41.7M +$37.2M +826,876 +6,242%
Charles Schwab
34
Charles Schwab
California
$41.7M +$912K +20,272 +2%
Dimensional Fund Advisors
35
Dimensional Fund Advisors
Texas
$41.3M -$146K -3,236 -0.4%
Schroder Investment Management Group
36
Schroder Investment Management Group
United Kingdom
$41M +$2.4M +53,424 +7%
AQR Capital Management
37
AQR Capital Management
Connecticut
$40.1M -$30.7M -681,332 -46%
American Century Companies
38
American Century Companies
Missouri
$37.8M +$6.03M +134,048 +21%
Principal Financial Group
39
Principal Financial Group
Iowa
$33.3M +$169K +3,760 +0.6%
Macquarie Group
40
Macquarie Group
Australia
$32.5M -$2.18M -48,472 -7%
SCP
41
Sandhill Capital Partners
New York
$32.1M +$504K +11,208 +2%
Bank of America
42
Bank of America
North Carolina
$29.5M +$7.86M +174,676 +42%
Goldman Sachs
43
Goldman Sachs
New York
$25.8M -$12.2M -271,544 -34%
RhumbLine Advisers
44
RhumbLine Advisers
Massachusetts
$24.8M -$614K -13,652 -3%
Citadel Advisors
45
Citadel Advisors
Florida
$22.7M +$13.3M +295,336 +183%
Royal Bank of Canada
46
Royal Bank of Canada
Ontario, Canada
$22M +$1.29M +28,572 +7%
CS
47
Candriam SCA
Luxembourg
$21.5M +$4.31M +95,712 +28%
PPA
48
Parametric Portfolio Associates
Washington
$21.3M -$946K -21,020 -5%
ACM
49
American Capital Management
New York
$20.8M +$689K +15,320 +4%
SIMG
50
Stephens Investment Management Group
Texas
$18.9M -$201K -4,456 -1%

TECH Hedge Fund Activity: Q1 2019 in Review

355 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q1 2019, worth a combined $7.06B — up 38% from $5.12B a quarter earlier.

Buyers outnumbered sellers: 56 funds opened new TECH positions and 24 closed out — a net gain of 32 holders — while 127 added to existing stakes and 110 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $46.2M. The largest seller was AQR Capital Management, cutting an estimated $30.7M.

  • 355 institutional investors held Bio-Techne (TECH) as of Q1 2019, up from 327 in Q4 2018.
  • Funds reported $7.06B of Bio-Techne stock for Q1 2019, up 38% quarter-over-quarter.
  • 56 funds opened new Bio-Techne positions in Q1 2019 and 24 closed out, a net change of +32 holders.
  • The largest Bio-Techne buyer in Q1 2019 was Wellington Management Group, an estimated $46.2M added.
  • The largest Bio-Techne seller in Q1 2019 was AQR Capital Management, an estimated $30.7M sold.

Based on aggregated 13F filings for Q1 2019.